Foundation for Neglected Disease Research (FNDR) is a non-profit biotech R&D organization focusing on discovery and development of drugs, diagnostics and solutions for infectious diseases with a high socio-economic impact, such as tuberculosis, malaria, dengue, rabies, leishmania, and more recently COVID-19. 

Since its inception in 2014, FNDR has won numerous Indian and international awards and grants in areas of tuberculosis, bacterial biomarkers, malaria, including multiple grants from Government of India. FNDR also holds patents on various drug candidates, one of which is in Phase 2 clinical trial for tuberculosis, in collaboration with Bill and Melinda Gates Medical Research Institute and Global TB Alliance (https://clinicaltrials.gov/ct2/show/NCT04176250).   

FNDR has a team of 16 scientists, consisting of medicinal chemists, microbiologists, immunologists, molecular biologists, biochemists, pharmacologists, veterinarians, and people with drug development and techno-commercial expertise ranging from 2-25 years, who have collectively delivered over 20 clinical candidates for various indications.  

FNDR is housed in a 10,000 sq. ft. R&D Centre in north Bangalore, India. It has state-of-the-art BSL-2 and BSL-3 facilities with both in-vitro and in-vivo capabilities, including animal biocontainment units with individually ventilated cages (IVC’s). The facility also has a complete set-up with DMPK, Bioanalytical and Chemistry and virology labs for drug discovery. The In-vitro and in-vivo BSL-3 biosafety containment laboratories are registered with the Department of Biotechnology (DBT), Institutional Biosafety Committee (IBSC), and CPCSEA-Institutional animal ethics committee (IAEC).